Familial Hypercholesterolaemia

Familial Hypercholesterolaemia

Familial Hypercholesterolaemia (FH) is a genetic disorder characterised by high LDL-cholesterol levels causing premature cardiovascular disease. Although one of the most common inherited conditions, affecting around 1 in 500 people, it is asymptomatic and therefore under-diagnosed with 85% of those affected remaining unidentified (Marks et al, 2004).

The key to improving outcomes is early identification and initiation of treatment, effectively eliminating the excess cardiovascular risk (Betteridge et al, 1999; Neil et al, 2008; Vermissen et al, 2008).

NewGene offers a two-step testing regime with a rapid low cost genotype assay for common mutations, followed by full gene sequencing if required. In the North East and North Cumbria region the clinical phenotype as measured on the Dutch Clinic Score is used to determine the testing process.

Additional details and publications regarding this test can be accessed by following this link to the Case Studies page.

Contact us

NewGene Limited
Bioscience Building
International Centre for Life
Newcastle upon Tyne
NE1 4EP, UK

Tel: +44 (0)191 242 1923
Fax: +44 (0)191 241 8799
Email: info@newgene.org.uk

Click here for location map

Mon – Fri 08:30 to 17:00, closed Bank Holidays

An ISO 15189 accredited Medical Laboratory company

NewGene Limited | Company Number: 06735445

Technology Partners

Agilent Technologies

Agena Bioscience

Illumina

Sophia Genetics

Qiagen

Promega

Enquiry form